ABT · 10-Q · 2026Q2 · Full report

Operating Cash Flow and Capex

ABBOTT LABORATORIES · 2026-07-28 · Importance 94 · Surprise 100 · From source text

Net cash from operating activities increased 9.8% to $3.803 billion for the first six months of 2026 from $3.464 billion. Investing activities used $20.997 billion, including $19.962 billion for acquisitions of businesses and technologies, compared with $1.052 billion of investing cash use in the prior-year period. Financing activities provided $13.795 billion, primarily reflecting $19.827 billion of long-term debt proceeds, offset by $2.821 billion of debt repayments, $1.225 billion of share repurchases, and $2.200 billion of dividends. Ending cash declined to $5.104 billion from $8.522 billion at December 31, 2025.

Key facts

• Net cash used in investing activities for the six months ended June 30, 2026: $(20,997) million and for the six months ended June 30, 2025: $(1,052) million.
• Net cash from operating activities for the first six months of 2026 totaled $3.8 billion, an increase of $339 million from the prior year.
• Net cash from operating activities for the six months ended June 30, 2026: $3,803 million and for the six months ended June 30, 2025: $3,464 million.
• Net cash from operating activities in the first six months of 2026 included the payment of cash taxes of $856 million.

Impact estimates